Skip to content
October 25–27, 2027 · Orlando

Talk Details · Diabetes 2025

Prevalence and pattern of dyslipidemia and its associated factors among patients of type 2 Diabetes Mellitus in India

Keynote · Virtual · Day 3

Abstract

About this talk

Background: Dyslipidemia is a common comorbidity in type 2 diabetes mellitus (T2DM) and contributes to cardiovascular disease. Understanding the associations between anthropometric indices and lipid parameters is important for risk stratification.

Methods: A cross-sectional study was conducted in adults with T2DM. Data collected included age, body mass index (BMI), waist circumference (WC), lipid parameters (total cholesterol [TC], LDL-C, HDL-C, triglycerides [TG], TC/HDL ratio), and comorbidities (hypertension, dyslipidemia, coronary artery disease [CAD], chronic kidney disease [CKD]). Lipid levels were classified using standard criteria. Pearson’s correlation was used to assess associations between anthropometric measures and lipid parameters.

Results: A total of 51 patients with T2DM (22 males, 29 females) were included. Median age was 59 years and median BMI was 26.2 kg/m². Comorbidities included hypertension (58.8%), dyslipidemia (76.5%), CAD (9.8%), and CKD (9.8%). Median lipid values were TC 166 mmol/L, LDL-C 92.2 mmol/L, HDL-C 49 mmol/L, and TG 214 mmol/L. Hypertriglyceridemia (60.8%) and low HDL-C (17.6%) were the most frequent lipid abnormalities. BMI showed an inverse correlation with TC (r = –0.2823, p = 0.047), and WC showed an inverse correlation with HDL-C (r = –0.2893, p = 0.0395). No other significant associations were observed.

Conclusion: Among adults with T2DM in India, hypertriglyceridemia and low HDL-C were the predominant lipid abnormalities. BMI and WC demonstrated differential associations with lipid fractions, highlighting the importance of assessing both general and central adiposity in cardiovascular risk evaluation.

Speaker

About the speaker

Ashok Sharma

Ashok Sharma

Indraprastha Apollo Hospital, India

View full speaker profile →

Join the Diabetes 2027 delegation

Orlando · October 25–27, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.